Cyntellect Snags Customer for Cell Xpress Service

San Diego-based Cyntellect said last week that it has entered into a formal agreement with an undisclosed US-based biotechnology company to access its Cell Xpress service.

The agreement is the second publicly announced by Cyntellect since the service was launched in October 2004. Later that month, the company announced it had signed a partnership for Cell Xpress with Protein Design Labs (see Inside Bioassays, 11/2/2004).

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.